Lifelong statins for long life in dialysis patients?

ABSTRACT Dyslipidemia in chronic kidney disease (CKD) contributes to the increasing cardiovascular risk during progression of disease. Statins reduces ischemic events CKD patients not treated with dialysis and treatment is generally recommended above 50 years old. In on maintenance treatment, it initiate statins based evidence from randomized clinical trials. an article by Marx et al. this issue CKJ, a post hoc analysis 4D study diabetes mellitus shows different time trends for statin-treated compared those placebo group. Although numbers were different, increased over group whereas stabilized after 1.5 remained constant atorvastatin Editorial we discuss context current guidelines practice patients.